Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steen Pehrson

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
The American Journal of Cardiology|September 25, 2025
Implantable Cardioverter-Defibrillator and Frailty in Non-ischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up of the DANISH TrialJawad H Butt, Johan Skovgaard Bundgaard, Morten Schou, et al.
Circulation|October 21, 2020
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced TrialMilton Packer, Stefan D Anker, Javed Butler, et al.
JACC. Advances|August 14, 2025
Ventricular Tachycardia Predicts All-Cause Mortality and Nonsudden Cardiac Death in Nonischemic CardiomyopathySharif Omara, Thomas N Jensen, Lars Koeber, et al.
American Heart Journal|September 7, 2016
Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH)Jens Jakob Thune, Steen Pehrson, Jens Cosedis Nielsen, et al.
JACC. Heart Failure|July 15, 2019
Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit: Insights From the DANISH TrialSøren Lund Kristensen, Wayne C Levy, Ramin Shadman, et al.
European Journal of Heart Failure|August 19, 2024
Anthropometric measures and long-term mortality in non-ischaemic heart failure with reduced ejection fraction: Questioning the obesity paradoxJawad H Butt, Jens Jakob Thune, Jens C Nielsen, et al.
Circulation. Heart Failure|August 9, 2022
Efficacy of Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure According to Sex: Extended Follow-Up Study of the DANISH TrialJawad H Butt, Adelina Yafasova, Marie B Elming, et al.
JACC. Heart Failure|March 4, 2022
NT-proBNP and ICD in Nonischemic Systolic Heart Failure: Extended Follow-Up of the DANISH TrialJawad H Butt, Adelina Yafasova, Marie B Elming, et al.
Circulation|December 10, 2021
Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH SubstudyRune Boas, Nikolay Sappler, Lukas von Stülpnagel, et al.
The New England Journal of Medicine|August 30, 2016
Defibrillator Implantation in Patients with Nonischemic Systolic Heart FailureLars Køber, Jens J Thune, Jens C Nielsen, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
The American Journal of Cardiology|September 25, 2025
Implantable Cardioverter-Defibrillator and Frailty in Non-ischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up of the DANISH TrialJawad H Butt, Johan Skovgaard Bundgaard, Morten Schou, et al.
Circulation|October 21, 2020
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced TrialMilton Packer, Stefan D Anker, Javed Butler, et al.
JACC. Advances|August 14, 2025
Ventricular Tachycardia Predicts All-Cause Mortality and Nonsudden Cardiac Death in Nonischemic CardiomyopathySharif Omara, Thomas N Jensen, Lars Koeber, et al.
American Heart Journal|September 7, 2016
Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH)Jens Jakob Thune, Steen Pehrson, Jens Cosedis Nielsen, et al.
JACC. Heart Failure|July 15, 2019
Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit: Insights From the DANISH TrialSøren Lund Kristensen, Wayne C Levy, Ramin Shadman, et al.
European Journal of Heart Failure|August 19, 2024
Anthropometric measures and long-term mortality in non-ischaemic heart failure with reduced ejection fraction: Questioning the obesity paradoxJawad H Butt, Jens Jakob Thune, Jens C Nielsen, et al.
Circulation. Heart Failure|August 9, 2022
Efficacy of Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure According to Sex: Extended Follow-Up Study of the DANISH TrialJawad H Butt, Adelina Yafasova, Marie B Elming, et al.
JACC. Heart Failure|March 4, 2022
NT-proBNP and ICD in Nonischemic Systolic Heart Failure: Extended Follow-Up of the DANISH TrialJawad H Butt, Adelina Yafasova, Marie B Elming, et al.
Circulation|December 10, 2021
Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH SubstudyRune Boas, Nikolay Sappler, Lukas von Stülpnagel, et al.
The New England Journal of Medicine|August 30, 2016
Defibrillator Implantation in Patients with Nonischemic Systolic Heart FailureLars Køber, Jens J Thune, Jens C Nielsen, et al.
Pageof 11